Nuveen’s Avantax, Inc. Common Stock AVTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-123,300
Closed -$3.15M 3391
2023
Q3
$3.15M Sell
123,300
-4,823
-4% -$114K ﹤0.01% 2098
2023
Q2
$2.87M Sell
128,123
-61,551
-32% -$1.45M ﹤0.01% 2187
2023
Q1
$4.99M Buy
189,674
+51,874
+38% +$1.41M ﹤0.01% 1888
2022
Q4
$3.52M Sell
137,800
-6,554
-5% -$150K ﹤0.01% 2113
2022
Q3
$2.79M Sell
144,354
-3,127
-2% -$62.9K ﹤0.01% 2218
2022
Q2
$2.72M Sell
147,481
-259,918
-64% -$4.73M ﹤0.01% 2280
2022
Q1
$7.83M Sell
407,399
-9,149
-2% -$166K ﹤0.01% 1802
2021
Q4
$6.99M Sell
416,548
-97,253
-19% -$1.65M ﹤0.01% 1907
2021
Q3
$7.74M Sell
513,801
-59,703
-10% -$966K ﹤0.01% 1966
2021
Q2
$9.93M Sell
573,504
-49,741
-8% -$817K ﹤0.01% 1873
2021
Q1
$10.4M Sell
623,245
-65,220
-9% -$1.09M ﹤0.01% 1776
2020
Q4
$11M Sell
688,465
-32,001
-4% -$391K ﹤0.01% 1654
2020
Q3
$6.79M Buy
720,466
+27,318
+4% +$302K ﹤0.01% 1752
2020
Q2
$7.92M Buy
693,148
+45,698
+7% +$574K ﹤0.01% 1646
2020
Q1
$7.8M Sell
647,450
-6,698
-1% -$129K ﹤0.01% 1444
2019
Q4
$17.1M Buy
654,148
+229,304
+54% +$5.14M 0.01% 1262
2019
Q3
$9.19M Buy
424,844
+187,517
+79% +$4.73M ﹤0.01% 1627
2019
Q2
$7.21M Buy
+237,327
New +$7.81M ﹤0.01% 1791

Other funds holding AVTA

Nuveen's AVTA Position: Q4 2023 in Review

Nuveen sold out of Avantax, Inc. Common Stock (AVTA) in Q4 2023, closing a stake of 123,300 shares — an estimated $3.15M sold.

Nuveen first reported a position in AVTA in Q2 2019 and held it in 18 quarters. The position peaked at $17.1M in Q4 2019. 2 funds tracked by Wall St. Rank hold AVTA as of Q4 2023.

  • Nuveen reported no remaining Avantax, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Nuveen sold 123,300 Avantax, Inc. Common Stock shares in Q4 2023, an estimated $3.15M.
  • Nuveen first reported a position in Avantax, Inc. Common Stock in Q2 2019 and held it in 18 quarters.
  • Nuveen's Avantax, Inc. Common Stock position peaked at $17.1M in Q4 2019.
  • 2 funds tracked by Wall St. Rank held Avantax, Inc. Common Stock as of Q4 2023.

Based on Nuveen's 13F filing for Q4 2023, filed 14 Feb 2024.